← Open Payments lookup

KELLY GOVRO: Open Payments

NPI 1467638544 · SAINT CHARLES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,889 in 172 payments from 17 companies in 2025. Trend: 2023 $3,244 · 2024 $3,069 · 2025 $2,889

Food & beverage: $2,779Education: $109
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.18$409
ABBVIE INC.34$350
Teva Pharmaceuticals USA, Inc.11$294
Otsuka America Pharmaceutical, Inc.17$290
Vanda Pharmaceuticals Inc.20$278
Axsome Therapeutics, Inc.17$262
Alkermes, Inc.12$204
E.R. Squibb & Sons, L.L.C.9$167
Takeda Pharmaceuticals U.S.A., Inc.8$151
Janssen Pharmaceuticals, Inc7$151

Products named: INGREZZA, REXULTI, VRAYLAR, FANAPT, Auvelity, ARISTADA, COBENFY, AUSTEDO XR.

Industry payments across MO — which companies pay providers there.